Literature DB >> 19358800

When to suggest this OC alternative.

Kate Rowland1, Sarah-Anne Schumann.   

Abstract

Year:  2009        PMID： 19358800      PMCID： PMC3183925     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.

Authors:  C J Timmer; T M Mulders
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

Review 2.  Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk.

Authors:  John F Wilks
Journal:  Ann Pharmacother       Date:  2003-06       Impact factor: 3.154

3.  Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive.

Authors:  Julie E Schafer; Lauren M Osborne; Anne R Davis; Carolyn Westhoff
Journal:  Contraception       Date:  2006-01-03       Impact factor: 3.375

4.  Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.

Authors:  Kristjan Oddsson; Beate Leifels-Fischer; Nilson Roberto de Melo; Dominique Wiel-Masson; Chiara Benedetto; Carole H J Verhoeven; Thom O M Dieben
Journal:  Contraception       Date:  2005-03       Impact factor: 3.375

5.  Extended regimens of the contraceptive vaginal ring: a randomized trial.

Authors:  Leslie Miller; Carole H J Verhoeven; Johanna in't Hout
Journal:  Obstet Gynecol       Date:  2005-09       Impact factor: 7.661

6.  U.S. women's one-year contraceptive use patterns, 2004.

Authors:  Jennifer J Frost; Susheela Singh; Lawrence B Finer
Journal:  Perspect Sex Reprod Health       Date:  2007-03

7.  Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.

Authors:  Patricia J Sulak; Virginia Smith; Andrea Coffee; Iris Witt; Alicia L Kuehl; Thomas J Kuehl
Journal:  Obstet Gynecol       Date:  2008-09       Impact factor: 7.661
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.